Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Glass

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
European Journal of Pharmacology|April 1, 2024
Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonistsMonica Patel, Xiaoxi Zheng, Luli R Akinfiresoye, et al.
Neuroscience Letters|November 25, 2006
Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brainJohn C Ashton, Rosanna M A Rahman, Shiva M Nair, et al.
British Journal of Pharmacology|June 4, 2024
Positive allosteric modulation of the cannabinoid CB<sub>1</sub> receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kineticsHayley M Green, Jamie J Manning, Ian R Greig, et al.
Methods in Enzymology|July 29, 2017
Real-Time Measurement of Cannabinoid Receptor-Mediated cAMP SignalingMorag R Hunter, David B Finlay, Christa E Macdonald, et al.
British Journal of Pharmacology|November 23, 2021
Delineating the interactions between the cannabinoid CB<sub>2</sub> receptor and its regulatory effectors; β-arrestins and GPCR kinasesMonica Patel, Christoph Matti, Natasha L Grimsey, et al.
British Journal of Pharmacology|September 24, 2015
Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptorsWilliam J Redmond, Erin E Cawston, Natasha L Grimsey, et al.
Frontiers in Cellular Neuroscience|August 21, 2018
Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3<sup>R451C</sup> Mouse Model of AutismSuzanne Hosie, Daniel T Malone, Stephanie Liu, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2019
Divalent cannabinoid-1 receptor ligands: A linker attachment point survey of SR141716A for development of high-affinity CB1R molecular probesPhillip S Grant, Nils Kahlcke, Karan Govindpani, et al.
Frontiers in Pharmacology|December 8, 2018
Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-TriazinesCaitlin R M Oyagawa, Sara M de la Harpe, Yurii Saroz, et al.
Biochemical Pharmacology|February 24, 2020
Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonistsMonica Patel, Jamie J Manning, David B Finlay, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
European Journal of Pharmacology|April 1, 2024
Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonistsMonica Patel, Xiaoxi Zheng, Luli R Akinfiresoye, et al.
Neuroscience Letters|November 25, 2006
Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brainJohn C Ashton, Rosanna M A Rahman, Shiva M Nair, et al.
British Journal of Pharmacology|June 4, 2024
Positive allosteric modulation of the cannabinoid CB<sub>1</sub> receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kineticsHayley M Green, Jamie J Manning, Ian R Greig, et al.
Methods in Enzymology|July 29, 2017
Real-Time Measurement of Cannabinoid Receptor-Mediated cAMP SignalingMorag R Hunter, David B Finlay, Christa E Macdonald, et al.
British Journal of Pharmacology|November 23, 2021
Delineating the interactions between the cannabinoid CB<sub>2</sub> receptor and its regulatory effectors; β-arrestins and GPCR kinasesMonica Patel, Christoph Matti, Natasha L Grimsey, et al.
British Journal of Pharmacology|September 24, 2015
Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptorsWilliam J Redmond, Erin E Cawston, Natasha L Grimsey, et al.
Frontiers in Cellular Neuroscience|August 21, 2018
Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3<sup>R451C</sup> Mouse Model of AutismSuzanne Hosie, Daniel T Malone, Stephanie Liu, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2019
Divalent cannabinoid-1 receptor ligands: A linker attachment point survey of SR141716A for development of high-affinity CB1R molecular probesPhillip S Grant, Nils Kahlcke, Karan Govindpani, et al.
Frontiers in Pharmacology|December 8, 2018
Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-TriazinesCaitlin R M Oyagawa, Sara M de la Harpe, Yurii Saroz, et al.
Biochemical Pharmacology|February 24, 2020
Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonistsMonica Patel, Jamie J Manning, David B Finlay, et al.
Pageof 13